Phase 2 Dose-Rising Study of SOR007 Ointment for Actinic Keratosis
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 22 Jan 2018
At a glance
- Drugs Paclitaxel (Primary)
- Indications Actinic keratosis
- Focus Adverse reactions
- Sponsors Dfb Soria
- 16 Jan 2018 Planned End Date changed from 1 Jan 2018 to 1 Mar 2018.
- 16 Jan 2018 Planned primary completion date changed from 1 Jul 2017 to 1 Mar 2018.
- 16 Jan 2018 Status changed from recruiting to active, no longer recruiting.